Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of ...

Shares of this pharmaceutical company have returned -14.4% over the past month versus the Zacks S&P 500 composite's +4.3% change. The Zacks Large Cap Pharmaceuticals industry, to which Merck ...

In a presentation at JPMorgan’s healthcare investment conference in San Francisco late Monday, Merck executives presented a rosy picture as the company heads toward the 2028 patent expiration.

Investors with a lot of money to spend have taken a bullish stance on Merck & Co (NYSE:MRK). And retail traders should know. We noticed this today when the trades showed up on publicly available ...